Prediction of incident diabetes mellitus by baseline IGF1 levels.

OBJECTIVE IGF1 is associated with metabolic parameters and involved in glucose metabolism. Low-IGF1 has been implicated in the etiology of glucose intolerance and subjects with pathological causes of either low- or high-IGF1 are at risk of diabetes. We hypothesized that both low- and high-IGF1 levels increase the risk of diabetes and aimed to assess the role of IGF1 in the risk of developing diabetes in a large prospective study. DESIGN An analysis of two prospective cohort studies, the DETECT study and SHIP. METHODS We measured IGF1 levels in 7777 nondiabetic subjects and assessed incident diabetes mellitus during follow-up. RESULTS There were 464 cases of incident diabetes during 32 229 person-years (time of follow-up in the DETECT study and SHIP: 4.5 and 5 years respectively). There was no heterogeneity between both studies (P > 0.4). The hazard ratios (HRs) of incident diabetes in subjects with IGF1 levels below the 10th or above the 90th age- and sex-specific percentile, compared to subjects with intermediate IGF1 levels, were 1.44 (95% confidence interval (CI) 1.07-1.94) and 1.55 (95% CI 1.06-2.06) respectively, after multiple adjustment. After further adjustment for metabolic parameters, the HR for low-IGF1 became insignificant. Analysis of IGF1 quintiles revealed a U-shaped association of IGF1 with risk of diabetes. Results remained similar after exclusion of patients with onset of new diabetes within 1 year or with borderline glucose or HbA1c levels at baseline. CONCLUSIONS Subjects with low- or high-IGF1 level are at increased risk of developing diabetes.

[1]  A. Pfeiffer,et al.  The role of insulin-like growth factor (IGF) binding protein-2 in the insulin-mediated decrease in IGF-I bioactivity. , 2009, The Journal of clinical endocrinology and metabolism.

[2]  D. Nathan,et al.  International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes , 2009, Diabetes Care.

[3]  J. Shaw,et al.  International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes , 2009, Diabetes Care.

[4]  G. Brabant,et al.  Mortality and serum insulin-like growth factor (IGF)-I and IGF binding protein 3 concentrations. , 2009, The Journal of clinical endocrinology and metabolism.

[5]  N. Møller,et al.  Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. , 2009, Endocrine reviews.

[6]  J. Wylie-Rosett,et al.  The role of insulin‐like growth factor‐I and its binding proteins in glucose homeostasis and type 2 diabetes , 2009, Diabetes/metabolism research and reviews.

[7]  M. Kearney,et al.  The role of IGF‐I and its binding proteins in the development of type 2 diabetes and cardiovascular disease , 2008, Diabetes, obesity & metabolism.

[8]  K. Chien.  An Accurate Risk Score Based on Anthropometric, Dietary, and Lifestyle Factors to Predict the Development of Type 2 Diabetes , 2007, Diabetes Care.

[9]  Kurt Hoffmann,et al.  An Accurate Risk Score Based on Anthropometric, Dietary, and Lifestyle Factors to Predict the Development of Type 2 Diabetes , 2007, Diabetes Care.

[10]  Ralph B D'Agostino,et al.  Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. , 2007, Archives of internal medicine.

[11]  E. Feskens,et al.  The prevalence of the metabolic syndrome is increased in patients with GH deficiency, irrespective of long-term substitution with recombinant human GH. , 2007, European journal of endocrinology.

[12]  S. Melmed.  Medical progress: Acromegaly. , 2006, The New England journal of medicine.

[13]  S. Silber,et al.  Cardiovascular risk factors in primary care: methods and baseline prevalence rates – the DETECT program , 2005, Current medical research and opinion.

[14]  G. Bergström,et al.  Bovine growth hormone transgenic mice are resistant to diet-induced obesity but develop hyperphagia, dyslipidemia, and diabetes on a high-fat diet. , 2005, Endocrinology.

[15]  C. Meisinger,et al.  C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998. , 2003, Archives of internal medicine.

[16]  Yoav Ben-Shlomo,et al.  A putative functional polymorphism in the IGF-I gene: association studies with type 2 diabetes, adult height, glucose tolerance, and fetal growth in U.K. populations. , 2002, Diabetes.

[17]  D. Dunger,et al.  Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study , 2002, The Lancet.

[18]  S. Haffner,et al.  Identification of Persons at High Risk for Type 2 Diabetes Mellitus: Do We Need the Oral Glucose Tolerance Test? , 2002, Annals of Internal Medicine.

[19]  A. Hofman,et al.  A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. , 2001, Diabetes.

[20]  D. Clayton,et al.  Statistical Models in Epidemiology , 1993 .

[21]  John B. Willett,et al.  It’s About Time: Using Discrete-Time Survival Analysis to Study Duration and the Timing of Events , 1993 .

[22]  R. Royall.  Model robust confidence intervals using maximum likelihood estimators , 1986 .

[23]  J M Robins,et al.  Estimation of a common effect parameter from sparse follow-up data. , 1985, Biometrics.

[24]  M. Ohrvall,et al.  Effects of gastric bypass on the GH/IGF-I axis in severe obesity--and a comparison with GH deficiency. , 2006, European journal of endocrinology.

[25]  U. John,et al.  Study of Health in Pomerania (SHIP): A health examination survey in an east German region: Objectives and design , 2005, Sozial- und Präventivmedizin.

[26]  B. Li,et al.  A general and islet cell-enriched overexpression of IGF-I results in normal islet cell growth, hypoglycemia, and significant resistance to experimental diabetes. , 2008, American journal of physiology. Endocrinology and metabolism.